The AI transformation underway in life sciences regulatory affairs is understated, yet tangible and grounded. It is a quiet revolution: instead of pursuing speculative intelligence, organizations are applying AI to automate predictable, rules-driven regulatory work.
The post The Quiet Revolution of AI in Regulatory Affairs appeared first on Yseop.
Why do AI pilots fail to scale in life sciences regulatory teams? Based on our experience supporting AI adoption in regulatory environments worldwide, this article explains what successful teams do differently.
The post What Does Successful AI Adoption Look Like in Regulatory Affairs? appeared first on Yseop.
The promise of AI in pharma has been circulating for years. In 2025, the industry stopped talking about potential and started designing around it.
The post 2025: The Year Pharma Crossed the AI Threshold appeared first on Yseop.
Yseop’s first CMC-focused offering automates the Quality Overall Summary (Module 2.3), a central component of regulatory submissions that pulls structured insights from Module 3.2.
The post Yseop Expands into CMC: Redefining Regulatory Automation Beyond Clinical appeared first on Yseop.